Top Suppliers:I want be here

34202-69-2

34202-69-2 structure
34202-69-2 structure
  • Name: Hexafluoroacetone trihydrate
  • Chemical Name: 1,1,1,3,3,3-hexafluoropropan-2-one,trihydrate
  • CAS Number: 34202-69-2
  • Molecular Formula: C3H6F6O4
  • Molecular Weight: 220.068
  • Create Date: 2018-06-24 17:09:07
  • Modify Date: 2024-01-02 16:33:59

Name 1,1,1,3,3,3-hexafluoropropan-2-one,trihydrate
Synonyms Perfluoroacetone trihydrate
2-Propanone,hexafluoro-,trihydrate
Hexafluoroacetone Hydrate
GC 7787
2-Propanone, 1,1,1,3,3,3-hexafluoro-, hydrate (1:3)
Hexafluoro-2-propanone trihydrate
Acetone,hexafluoro-,trihydrate
1,1,1,3,3,3-hexafluoropropan-2-one trihydrate
Hexafluoro-2-propanone Hydrate
EINECS 211-676-3
1,1,1,3,3,3-Hexafluoroacetone trihydrate
MFCD00149061
Hexafluoro-2-propanone
Hexafluoroacetone trihydrate
Density 1.579 g/mL at 25 °C(lit.)
Boiling Point 106-108 °C
Melting Point 18-21 °C(lit.)
Molecular Formula C3H6F6O4
Molecular Weight 220.068
Flash Point 105-106°C
Exact Mass 220.017029
PSA 44.76000
LogP 1.48720
Vapour Pressure 87.5 psi ( 21 °C)
Index of Refraction n20/D 1.319(lit.)

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UC2700000
CHEMICAL NAME :
2-Propanone, hexafluoro-, trihydrate
CAS REGISTRY NUMBER :
34202-69-2
LAST UPDATED :
199504
DATA ITEMS CITED :
7
MOLECULAR FORMULA :
C3-F6-O.3H2-O
MOLECULAR WEIGHT :
220.09
WISWESSER LINE NOTATION :
FXFFXQQXFFF &QH 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
190 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 7,592,1965
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
113 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Skin and Appendages - primary irritation (after topical exposure)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 7,592,1965 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
275 mg/kg
SEX/DURATION :
female 6-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 47,35,1979
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
275 mg/kg
SEX/DURATION :
female 6-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 47,35,1979
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
55 mg/kg
SEX/DURATION :
female 6-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 47,35,1979
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
11 mg/kg
SEX/DURATION :
female 6-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 47,35,1979 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5871 No. of Facilities: 48 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 1441 (estimated) No. of Female Employees: 432 (estimated)
Symbol GHS05 GHS06 GHS08
GHS05, GHS06, GHS08
Signal Word Danger
Hazard Statements H301 + H331-H310-H314-H361
Precautionary Statements P261-P280-P301 + P310-P302 + P350-P305 + P351 + P338-P310
Personal Protective Equipment Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
Hazard Codes T:Toxic
Risk Phrases R23/24/25;R34;R63
Safety Phrases S26-S36/37/39-S45
RIDADR UN 2552 6.1/PG 2
WGK Germany 3
RTECS UC2700000
Packaging Group II
Hazard Class 6.1
HS Code 2915900090
HS Code 2915900090
Summary 2915900090 other saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:5.5% General tariff:30.0%